Press Releases of the MPI for Experimental Medicine until 2021

List is filtered with:

reset filter

Degradation and reconstruction of myelin sheaths characterize brain diseases such as multiple sclerosis. Researchers at the Max Planck Institute for Experimental Medicine found out: Not only the myelin-forming cells themselves, but also nerve cells make an important contribution to the regeneration of myelin sheaths. more

Neurobiologists have long wondered how fatigue-free signal transmission is made possible. Researchers have now discovered an important regulatory mechanism that enables synapses of nerve cells to function reliably even over longer periods of time and during high-frequency activity. (in German) more

Genetic newborn screening and artificial intelligence are to accelerate diagnosis for patients with rare diseases. The project, with the participation of researchers from the Max Planck Institute for Experimental Medicine and the University Medical Center Göttingen, was launched on October 1, 2021. more

Only a few substances cross the blood-brain barrier uncontrollably. Researchers at the Max Planck Institute of Experimental Medicine have now discovered that the inhalation anesthetic Isoflurane switches on an import pathway across the blood-brain barrier. more

In his podcast #wissenschafftzukunft, Lower Saxony's Science Minister Björn Thümler talks with brain researcher Hannelore Ehrenreich about the importance of basic research in the Corona pandemic and how the head of clinical neuroscience at the Max Planck Institute for Experimental Medicine plans to fight Covid-19 with Epo. more

Triple STED microscopy enables in vivo super-resolution of synapses by quasi-simultaneous imaging of three different proteins. more

Super-resolution STED microscopy for the first time enables the long-term observation of synapses in the healthy and diseased brain more

Go to Editor View